Page last updated: 2024-12-05

xanthenes

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Xanthenes: Compounds with three aromatic rings in linear arrangement with an OXYGEN in the center ring. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7107
CHEMBL ID486760
CHEBI ID10057
SCHEMBL ID4267
MeSH IDM0023042

Synonyms (46)

Synonym
dibenzo[a,e]pyran
CHEBI:10057 ,
10h-9-oxaanthracene
nsc46931
nsc-46931
9h-xanthene
inchi=1/c13h10o/c1-3-7-12-10(5-1)9-11-6-2-4-8-13(11)14-12/h1-8h,9h
xanthene
C01464
xanthan ,
92-83-1
xanthene, 99%
nsc 46931
ai3-01544
einecs 202-194-4
brn 0133939
smr000857210
MLS001333246
MLS001333245
X0003
CHEMBL486760
NCGC00247062-01
a762z8101y ,
5-17-02-00252 (beilstein handbook reference)
unii-a762z8101y
xanthenes
HMS2231P24
AKOS016008734
FT-0603304
AE-562/43285774
HMS3371P15
SCHEMBL4267
DTXSID1059070
dibenzopyran, tricyclic
mfcd00005055
9-oxa-9,10-dihydroanthracene
Q413791
4-(acetoxymethyl)benzeneboronicacid
D70448
xanthene-
AS-56278
A859966
CS-W017106
EN300-7407236
Z1255415427
bdbm50599592

Research Excerpts

Overview

DKxanthenes are a class of yellow secondary metabolites produced by myxobacterial genera.

ExcerptReferenceRelevance
"Xanthenes are a special class of oxygen-incorporating tricyclic compounds. "( Xanthenes in Medicinal Chemistry - Synthetic strategies and biological activities.
Durães, F; Maia, M; Pinto, MMM; Resende, DISP; Sousa, E, 2021
)
3.51
"DKxanthenes are a class of yellow secondary metabolites produced by myxobacterial genera "( Genetic and Functional Analyses of the DKxanthene Biosynthetic Gene Cluster from
Cho, K; Hyun, H; Lee, JS; Lee, S, 2018
)
1.2

Toxicity

ExcerptReferenceRelevance
" The ip LD50 values of 37, 31, and 27 mg/kg were obtained for Charles River CD-1, Texas (ICR), and Sprague-Dawley (CF-1) strains of mice, respectively."( Toxicity of Secalonic acid D.
Ciegler, A; Hayes, AW; Reddy, CS; Williams, WL, 1979
)
0.26
" Body weights, toxic signs, and mortality were used to arrive at no observable effect level (NOEL)."( Neurotoxic effects of secalonic acid D in mice during subchronic postnatal exposure.
Montella, PG; Reddy, CS, 1991
)
0.28
" Both Pt(Pyronin Y)2 and Pt(Thioflavin)2 were more toxic than the thiazin complexes."( Cytotoxicity, radiosensitization, and DNA interaction of platinum complexes of thiazin and xanthene dyes.
Herman, TS; Kaufmann, ME; Teicher, BA, 1990
)
0.28
" The LD50 values as established in the first two experiments were 10."( Acute toxicity of sterigmatocystin to chicks.
Frohlich, AA; Marquardt, RR; Sreemannarayana, O, 1987
)
0.27
"The penetration of sulforhodamine B (SRB) into the two corneas of a freshly killed mouse was measured after one eye was briefly exposed to a solution of a possibly toxic substance."( A permeability test for acute corneal toxicity.
Maurice, D; Singh, T, 1986
)
0.27
" At doses of rhodamine 123 which were toxic to carcinoma cells, the conversion of mitochondrial-specific to cytoplasmic-nonspecific localization of the drug was observed prior to cell death."( Selective toxicity of rhodamine 123 in carcinoma cells in vitro.
Bernal, SD; Chen, LB; Lampidis, TJ; Summerhayes, IC, 1983
)
0.27
" Dose response was studied by intragastric and intratracheal instillation, and SAD was given in suspension in Krebs-Ringer phosphate solution at doses well below the reported LD50 values for both rats and mice."( Secalonic acid D toxicity in rat lung.
Ciegler, A; Green, FH; Sorenson, WG; Vallyathan, V, 1982
)
0.26
"00 mg/l was highly toxic to Streptococcus mutans, probably due to inhibition of dehydrogenase activity, and the extent of toxicity was closely associated with concentration."( Amphiphilic property of chlorhexidine and its toxicity against Streptococcus mutans GS-5.
Jitpukdeebodintra, S; Koontongkaew, S, 1994
)
0.29
"Membrane-permeating, fluorescent Ca2+ indicators have been used to investigate the role of increased intracellular Ca2+ (Ca2+i) levels in excitotoxic neuronal injury, but their ability to chelate Ca2+i and their own toxic effects in some cells could obscure this relationship."( Calcium indicators and excitotoxicity in cultured cortical neurons.
Ahern, KV; Chan, J; Greenberg, DA; Lustig, HS, 1993
)
0.29
" It is concluded that a) plasma membrane indicator dyes, not neutral red, might be better indicators of cytotoxicity occurring during cryopreservation; b) DMSO might be toxic to lysosomes during cryopreservation of cultured cells; and c) although [Ca+2]e can contribute to cytotoxicity, the presence of [Ca+2]e might not influence cryopreservation-induced cytotoxicity."( Extracellular calcium does not contribute to cryopreservation-induced cytotoxicity.
Baust, J; Danks, AM; Im, J; Isaacson, RL; Rhoads, LS; Van Buskirk, RG; Warner, A, 1993
)
0.29
" In general, catechol isoquinolines were more toxic than isoquinolines without catechol structure."( Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells.
Deng, Y; Dostert, P; Maruyama, W; Nakahara, D; Naoi, M; Niwa, T; Ohta, S; Takahashi, T, 1997
)
0.3
" Lens Plus was not toxic to cell glycolysis, respiration, and proliferation for up to 20% v/v."( Cytotoxicity evaluation of multipurpose contact lens solutions using an in vitro test battery.
Huff, JW; Pham, XT, 1999
)
0.3
" A high throughout in vitro toxicity screen has been developed and validated to identify compounds that have a high potential to be acutely toxic in vivo."( Development of a high throughput in vitro toxicity screen predictive of high acute in vivo toxic potential.
Casartelli, A; Day, C; Evans, SM; George, E; Herreros, E; Minnick, DT; Westmoreland, C,
)
0.13
" An in vitro model was developed to study the direct toxic effects that follow the metabolic activation of chemicals."( A Genetically engineered cell-based system for detecting metabolism-mediated toxicity.
Bull, S; Clothier, R; Coecke, S; Langezaal, I,
)
0.13
" Concentrations of AA above 10 microM were toxic to RGCs."( Protective effect of arachidonic acid on glutamate neurotoxicity in rat retinal ganglion cells.
Barnstable, CJ; Han, MH; Hirata, K; Kawasaki, A; Otori, Y; Wei, JY, 2002
)
0.31
" Human hepatoma (HepG2) cells in 96-well culture plates were exposed to known toxic (cisplatin, 5-fluorouracil, ethionine, flufenamic acid, and diflunisal) and control (transplatin, 5-chlorouracil, methionine, and acetylsalicylic acid) compounds for 1-3 days, and resazurin (5 micromol/L) was added."( An improved resazurin-based cytotoxicity assay for hepatic cells.
Gunnett, JW; Johnson, MD; Li, L; McMillian, MK; Parker, JB; Patel, L; Powers, WJ; Zhong, Z, 2002
)
0.31
" In addition, we found that rosiglitazone, although less toxic in the study population, was cytotoxic to hepatocytes in some donors (EC(50)<100 microM)."( Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors.
Fackett, A; Hayden, MJ; Hewitt, NJ; Li, AP; Lloyd, S; Sakai, Y; Silber, PM, 2002
)
0.31
" However, until now conflicting data have been presented regarding the role of biotransformation products in the adverse effects of OTA."( Metabolism-mediated cytotoxicity of ochratoxin A.
Bull, S; Fink-Gremmels, J; Simarro Doorten, AY; van der Doelen, MA, 2004
)
0.32
"Here we show the results of comparing cell viability, cytotoxicity, and apoptosis assays for measuring the time- and dose-dependent toxic effects of tamoxifen on HepG2 cells."( Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays.
Moravec, RA; Riss, TL, 2004
)
0.32
" Despite its clinical use, concerns remain regarding the potential toxic side-effects, such as nephrotoxicity, in equine patients, particularly after repeated dosing."( Gentamicin nephrotoxicity--a comparison of in vitro findings with in vivo experiments in equines.
Bull, S; Klein, WR; Laffont, CM; van der Harst, MR, 2005
)
0.33
" These assays were carried out with different dosages of several toxic compounds with the following permanent cell lines: human liver (Hep G2), human endometrium (ECC-1), human cervix (HeLa) and Chinese hamster ovary (CHO) cells."( Cytotoxic effects of 110 reference compounds on HepG2 cells and for 60 compounds on HeLa, ECC-1 and CHO cells. II mechanistic assays on NAD(P)H, ATP and DNA contents.
de Roos, JA; Débiton, E; Schoonen, WG; Westerink, WM, 2005
)
0.33
" Cytotoxicity test methods are useful for screening because they serve to separate toxic from nontoxic materials, providing predictive evidence of compound safety."( Comparison of in vitro assays of cellular toxicity in the human hepatic cell line HepG2.
De Groene, EM; Klaffke, W; Miret, S, 2006
)
0.33
"All monomers showed toxic effects on the HGFs and HaCaT cells and inhibited chemical reduction of Alamar Blue in high concentrations."( Cytotoxicity of resin monomers on human gingival fibroblasts and HaCaT keratinocytes.
Brook, IM; Moharamzadeh, K; Scutt, AM; Van Noort, R, 2007
)
0.34
"Dental resin monomers are toxic to human gingival fibroblasts and HaCaT keratinocytes."( Cytotoxicity of resin monomers on human gingival fibroblasts and HaCaT keratinocytes.
Brook, IM; Moharamzadeh, K; Scutt, AM; Van Noort, R, 2007
)
0.34
" The chemical sodium o-benzyl-p-chlorophenol was consistently ranked the most toxic of the tested compounds with each cell line and the endpoints employed."( In vitro cytotoxicity assessment of the biocidal agents sodium o-phenylphenol, sodium o-benzyl-p-chlorophenol, and sodium p-tertiary amylphenol using established fish cell lines.
Davoren, M; Fogarty, AM, 2006
)
0.33
" This bioassay can detect toxic effects of a range of fungicides from different chemical classes with different modes of action."( A rapid resazurin bioassay for assessing the toxicity of fungicides.
Fai, PB; Grant, A, 2009
)
0.35
" We hypothesize that SWCNT may be toxic to the skin."( Oxidative stress and inflammatory response in dermal toxicity of single-walled carbon nanotubes.
Castranova, V; Kagan, VE; Kisin, E; Kommineni, C; Leonard, SS; Murray, AR; Shvedova, AA; Young, SH, 2009
)
0.35
" This study evaluated the importance of astrocytes when predicting acute toxic potential using a neuronal screening battery of pure neuronal (NT2."( Evaluation of the importance of astrocytes when screening for acute toxicity in neuronal cell systems.
Coleman, MD; Hill, EJ; Woehrling, EK, 2010
)
0.36
" The absence of a specific treatment and the necessity of effective and safe drugs against these etiologic agents have stimulated the search for new antiprotozoal drugs with high activity, low toxicity to the animal, and low cost."( Cytotoxicity of solubilization vehicles for Trichomonas gallinae and Tritrichomonas foetus measured by the resazurin microtiter assay.
Carli, GA; Duarte, M; Giordani, RB; Macedo, AJ; Tasca, T; Zuanazzi, JA, 2009
)
0.35
" The toxic response of the PAMAM dendrimers correlated well with the number of surface primary amino groups, with increasing number resulting in an increase in toxic response."( Reactive oxygen species (ROS) induced cytokine production and cytotoxicity of PAMAM dendrimers in J774A.1 cells.
Byrne, HJ; Davoren, M; Lyng, FM; Naha, PC, 2010
)
0.36
"Ecasol present as a residual disinfectant in DUWL output water is very unlikely to have adverse effects on human oral tissues at levels effective in maintaining DUWL output water quality at better than potable standard water quality."( Lack of cytotoxicity by Trustwater Ecasol™ used to maintain good quality dental unit waterline output water in keratinocyte monolayer and reconstituted human oral epithelial tissue models.
Boyle, MA; Coleman, DC; O'Donnell, MJ; Russell, RJ, 2010
)
0.36
"Dual orthosteric agonists of metabotropic glutamate 2 (mGlu2) and mGlu3 receptors are being developed as novel antipsychotic agents devoid of the adverse effects of conventional antipsychotics."( Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 an
Battaglia, G; Britton, TC; Bruno, V; Cannella, M; Caraci, F; Copani, A; Drago, F; Giuffrida, ML; Heinz, BA; Merlo, S; Molinaro, G; Nicoletti, F; Nisenbaum, ES; Riozzi, B; Sortino, MA; Traficante, A; Wang, X, 2011
)
0.37
" One main side effect is permanent sensorineural hearing loss, induced by selective inner ear sensory hair cell death."( Functional hair cell mechanotransducer channels are required for aminoglycoside ototoxicity.
Alharazneh, A; Cheng, AG; Huth, M; Luk, L; Monfared, A; Ricci, AJ; Steyger, PS, 2011
)
0.37
" For 59 toxic reference compounds, an evaluation for both assays was carried up to 10(-3)M."( Cytotoxic effects of 109 reference compounds on rat H4IIE and human HepG2 hepatocytes. III: Mechanistic assays on oxygen consumption with MitoXpress and NAD(P)H production with Alamar Blue™.
Horbach, GJ; Schoonen, WG; Stevenson, JC; Westerink, WM, 2012
)
0.38
" The aim was to develop a test system that was capable of examining both genotoxicity and cytotoxicity on the basis of the metabolic health of the cells so as to provide a better assessment of the negative influence of toxic effects on the evaluation of genotoxicity."( Modification of the umu-assay (ISO 13829) accounting for cytotoxicity in genotoxicity assessment: a preliminary study.
Ahlf, W; Gutiérrez, IR; Toolaram, AP, 2012
)
0.38
"Both the QMix™ and NaOCl solutions were toxic to human bone marrow MSCs."( Cytotoxicity of QMix™ endodontic irrigating solution on human bone marrow mesenchymal stem cells.
Aldahmash, AM; Alkahtani, A; Alkahtany, SM; Anil, S; Elsafadi, MA; Mahmood, A, 2014
)
0.4
"Within the limitations of this in vitro study it can be concluded that NaOCl is toxic to the human bone marrow MSCs."( An in vitro evaluation of the cytotoxicity of varying concentrations of sodium hypochlorite on human mesenchymal stem cells.
Alkahtani, A; Alkahtany, SM; Anil, S, 2014
)
0.4
" Moreover our data clearly show that nanoparticle internalization and observed adverse effects are not necessarily associated."( Specific uptake and genotoxicity induced by polystyrene nanobeads with distinct surface chemistry on human lung epithelial cells and macrophages.
Aguerre-Chariol, O; Blazy, K; Braun, A; Chevillard, S; Dekali, S; Gamez, C; Grall, R; Kortulewski, T; Lacroix, G; Paget, V; Rat, P, 2015
)
0.42
" Taken together, micron-sized Ni (Ni-m1) was more reactive and toxic compared to the nano-sized Ni."( Nickel Release, ROS Generation and Toxicity of Ni and NiO Micro- and Nanoparticles.
Di Bucchianico, S; Elihn, K; Hedberg, J; Karlsson, HL; Latvala, S; Möller, L; Odnevall Wallinder, I, 2016
)
0.43
" Etoposide and teniposide, were 5-10 times less toxic to differentiated neurons compared to the mix of all cells in monolayer cultures."( Separating chemotherapy-related developmental neurotoxicity from cytotoxicity in monolayer and neurosphere cultures of human fetal brain cells.
Al-Rubai, AJ; Grabowska, AM; Ivanov, DP; Pratten, MK, 2016
)
0.43
"The development of safe antimicrobial agents is important for the effective treatment of pathogens."( Cytotoxicity Assays as Predictors of the Safety and Efficacy of Antimicrobial Agents.
Kretschmer, D; Zipperer, A, 2017
)
0.46
" faecalis, a Gram-positive and facultative anaerobic bacterial strain, and the most toxic chlorophenol, pentachlorophenol (PCP), were chosen as models for an anaerobe and toxicant, respectively."( Metabolic reduction of resazurin; location within the cell for cytotoxicity assays.
Chen, JL; Steele, TWJ; Stuckey, DC, 2018
)
0.48
" We conclude that the PluriBeat assay is a novel method for predicting chemicals' adverse effects on embryonic development."( A novel human pluripotent stem cell-based assay to predict developmental toxicity.
Emnéus, JK; Holst, B; Lauschke, K; Meiser, I; Neubauer, JC; Rasmussen, MA; Rosenmai, AK; Schmidt, K; Taxvig, C; Vinggaard, AM, 2020
)
0.56
" In the present study, we compared the in vivo toxic effects of three aminoglycosides, gentamicin, amikacin, and etimicin, in zebrafish embryos."( A new aminoglycoside etimicin shows low nephrotoxicity and ototoxicity in zebrafish embryos.
Chen, D; Han, Y; Jiang, H; Jing, L; Li, R; Qian, X; Shao, W; Yin, Y; Zhong, D, 2021
)
0.62
" Therefore, administration of xanthenone along with tacrolimus could be a promising therapeutic strategy to reduce the adverse effects and increase the tolerability to tacrolimus immunosuppressive therapy."( Impact of the ACE2 activator xanthenone on tacrolimus nephrotoxicity: Modulation of uric acid/ERK/p38 MAPK and Nrf2/SOD3/GCLC signaling pathways.
Ali, FEM; Azouz, AA; Hersi, F; Hussein Elkelawy, AMM; Omar, HA, 2022
)
0.72

Pharmacokinetics

ExcerptReferenceRelevance
" The median elimination half-life times of hypericin were 24."( Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers.
Brockmöller, J; Kerb, R; Ploch, M; Roots, I; Staffeldt, B, 1994
)
0.29
"A double-blind, randomized, placebo-controlled parallel-group trial (phase I) was performed to evaluate the central pharmacodynamic effects of two hypericum extracts with different contents of hyperforin (0."( Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG.
Dimpfel, W; Sauer, S; Schellenberg, R, 1998
)
0.3
" The aim of this study was to further investigate these pharmacokinetic DMXAA-drug interactions in the rat model."( A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomide.
Ching, LM; Kestell, P; Paxton, JW; Tingle, MD; Zhou, S, 2001
)
0.31
" The cause of the species difference in the pharmacokinetic response to thalidomide by DMXAA is unknown, and indicates difficulties in predicting the outcome of such a combination in patients."( A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomide.
Ching, LM; Kestell, P; Paxton, JW; Tingle, MD; Zhou, S, 2001
)
0.31
"05), elimination half-life (2."( Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
Kestell, P; Paxton, JW; Tingle, MD; Zhou, S, 2002
)
0.31
" Its pharmacokinetic properties have been investigated using both in vitro and in vivo models, and the resulting data extrapolated to patients."( Predicting pharmacokinetics and drug interactions in patients from in vitro and in vivo models: the experience with 5,6-dimethylxanthenone-4-acetic acid (DMXAA), an anti-cancer drug eliminated mainly by conjugation.
Kestell, P; Paxton, JW; Zhou, S, 2002
)
0.31
" The results indicate that the pharmacokinetics of mangiferin at doses of 10-30 mg/kg reveals a linear relation, while doses of 30-100 mg/kg show a nonlinear pharmacokinetic phenomenon."( Pharmacokinetic study of free mangiferin in rats by microdialysis coupled with microbore high-performance liquid chromatography and tandem mass spectrometry.
Lai, L; Lin, JH; Lin, LC; Tsai, TH, 2003
)
0.32
" Pharmacokinetic parameters and tissue distribution were assessed."( Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity.
Davies, NM; Forrest, ML; Kwon, GS; Ohgami, Y; Remsberg, CM; Yáñez, JA, 2008
)
0.35
"49 nM) for mGluR2 as 1 but had a superior pharmacokinetic profile."( Synthesis, in vitro pharmacology, and pharmacokinetic profiles of 2-[1-amino-1-carboxy-2-(9H-xanthen-9-yl)-ethyl]-1-fluorocyclopropanecarboxylic acid and its 6-heptyl ester, a potent mGluR2 antagonist.
Chaki, S; Kawakita, Y; Nakazato, A; Saito, A; Sakagami, K; Taguchi, T; Yasuhara, A; Yoshikawa, R, 2008
)
0.35
" Because a patient taking digoxin may also take hawthorn, we investigated potential interference of hawthorn in serum digoxin measurements using immunoassays as well as pharmacodynamic interaction between hawthorn and digoxin."( Interference of hawthorn on serum digoxin measurements by immunoassays and pharmacodynamic interaction with digoxin.
Bick, RJ; Dasgupta, A; Kidd, L; Poindexter, BJ, 2010
)
0.36
"To study potential pharmacodynamic interaction between hawthorn and digoxin."( Interference of hawthorn on serum digoxin measurements by immunoassays and pharmacodynamic interaction with digoxin.
Bick, RJ; Dasgupta, A; Kidd, L; Poindexter, BJ, 2010
)
0.36
" To study the pharmacodynamic interaction between hawthorn and digoxin, we used an isolated adult rat cardiomyocyte system, measuring calcium transients by real-time fluorescence spectrophotometry."( Interference of hawthorn on serum digoxin measurements by immunoassays and pharmacodynamic interaction with digoxin.
Bick, RJ; Dasgupta, A; Kidd, L; Poindexter, BJ, 2010
)
0.36
"Because of interference of hawthorn with a digoxin immunoassay and pharmacodynamic interaction with digoxin, a patient receiving digoxin should avoid hawthorn."( Interference of hawthorn on serum digoxin measurements by immunoassays and pharmacodynamic interaction with digoxin.
Bick, RJ; Dasgupta, A; Kidd, L; Poindexter, BJ, 2010
)
0.36
" The fully validated method was successfully applied to the pharmacokinetic study of the analytes in rats."( Comparative pharmacokinetics of prim-O-glucosylcimifugin and cimifugin by liquid chromatography-mass spectrometry after oral administration of Radix Saposhnikoviae extract, cimifugin monomer solution and prim-O-glucosylcimifugin monomer solution to rats.
Chai, Y; Jia, J; Li, Y; Lv, L; Zhang, G; Zhang, H; Zhao, L; Zhou, G, 2012
)
0.38
" A pharmacodynamic in vitro model of biofilm was developed that allows characterization of the activity of antibiotics against viability and biomass by using in parallel capsulated (ATCC 49619) and noncapsulated (R6) reference strains."( Antibiotic activity against naive and induced Streptococcus pneumoniae biofilms in an in vitro pharmacodynamic model.
Tulkens, PM; Van Bambeke, F; Vandevelde, NM, 2014
)
0.4
" This study is aimed to assess the influence of atractylenolide I and prim-O-glucosylcimifugin on the pharmacokinetic profile of astragaloside IV so as to investigate the pharmacokinetic mechanisms of the Yu-ping-feng prescription."( Pharmacokinetic Interaction of astragaloside IV with atractylenolide I and prim-O-glucosylcimifugin in male Sprague Dawley rats.
Jin, Y; Li, J; Song, J; Zheng, SR, 2014
)
0.4
" This validated method was successfully applied to a pharmacokinetic study after intravenous injection administration of gambogenic acid in dogs at a dose of 1 mg/kg."( Ultra-high-performance liquid chromatography tandem mass spectrometry method for the determination of gambogenic acid in dog plasma and its application to a pharmacokinetic study.
Chen, JP; Wang, CY; Wang, DL; Wang, SS; Yang, LL, 2014
)
0.4
" The pharmacokinetic parameters of the two agents were compared."( Preparation of Neogambogic Acid Nanoliposomes and its Pharmacokinetics in Rats.
Cong, JZ; Hou, JF; Li, XM; Liu, JW; Liu, SJ; Tong, L; Zhang, Y, 2018
)
0.48
" The pharmacokinetics results in rats showed that GNA-NLC plasma concentration was significantly higher than that of common preparation of gambogic acid, with a half-life period of 10."( Preparation of Neogambogic Acid Nanoliposomes and its Pharmacokinetics in Rats.
Cong, JZ; Hou, JF; Li, XM; Liu, JW; Liu, SJ; Tong, L; Zhang, Y, 2018
)
0.48
" However, short biological half-life and low oral bioavailability severely limit its clinical application."( Preparation and preliminary pharmacokinetics study of GNA-loaded zein nanoparticles.
Chen, W; Cheng, W; Dong, Q; Hong, L; Qian, J; Wang, B; Zha, L; Zhang, C, 2019
)
0.51
" The in vitro release profile, in vivo pharmacokinetic experiments and tissue distribution of GNA-ZN-NPs were also evaluated."( Preparation and preliminary pharmacokinetics study of GNA-loaded zein nanoparticles.
Chen, W; Cheng, W; Dong, Q; Hong, L; Qian, J; Wang, B; Zha, L; Zhang, C, 2019
)
0.51
"GNA-ZN-NPs significantly enhanced the oral bioavailability and prolonged half-life of GNA, providing a promising oral drug delivery system to improve in vivo pharmacokinetic behaviour of GNA."( Preparation and preliminary pharmacokinetics study of GNA-loaded zein nanoparticles.
Chen, W; Cheng, W; Dong, Q; Hong, L; Qian, J; Wang, B; Zha, L; Zhang, C, 2019
)
0.51

Compound-Compound Interactions

ExcerptReferenceRelevance
" The results suggest a potential role for R123 in combination with hyperthermia in the treatment of malignant cells."( In vitro and in vivo cytotoxicity of rhodamine 123 combined with hyperthermia.
Chase, D; Goffney, WH; Kern, DH; Krag, DN; Storm, FK; Wong, JH, 1990
)
0.28
" Glucose deprivation induced by insulin, and combined with the inhibition of oxidative phosphorylation, produces an additive depression of tumor energetics."( Inhibition of tumor high-energy phosphate metabolism by insulin combined with rhodamine 123.
Arbeit, JM; Hubesch, A; Karczmar, GS; Toy, BJ; Weiner, MW, 1988
)
0.27
" Prenatal mortality was increased by Rh 123 in combination with 2-DOG, with values of 40%, 43%, or 41% dead or resorbed at Rh 123 doses of 8, 12, or 15 mg/kg/day, respectively."( Teratogenic effects of a lipophilic cationic dye rhodamine 123, alone and in combination with 2-deoxyglucose.
Hood, RD; Jones, CL; Ranganathan, PN; Ranganathan, S, 1988
)
0.27
"A method for visualization of individual human brain cells and their dendritic extensions in combination with immunofluorescence is described."( Dual channel confocal laser scanning microscopy of lucifer yellow-microinjected human brain cells combined with Texas red immunofluorescence.
Belichenko, PV; Dahlström, A, 1994
)
0.29
"1 cDNA were effective in combination with 25 mg/kg DMXAA."( Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
Ching, LM; Kanwar, JR; Kanwar, RK; Krissansen, GW; Pandey, S, 2001
)
0.31
" In this study we examined whether administration of N-acetyl-aspartyl-glutamate (NAAG) in combination with mild hypothermia could improve striatal neuroprotection in the endothelin-1 rat model."( Neuroprotective effect of N-acetyl-aspartyl-glutamate in combination with mild hypothermia in the endothelin-1 rat model of focal cerebral ischaemia.
Ebinger, G; Hachimi-Idrissi, S; Michotte, Y; Sarre, S; Van Hemelrijck, A, 2005
)
0.33
" In regenerative dentistry, these bone grafting materials are routinely combined with enamel matrix derivatives (EMD) in order to additionally enhance tissue regeneration."( In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives.
Al-Nawas, B; Götz, W; Kasaj, A; Klein, MO; Reichert, C; Smeets, R, 2009
)
0.35
" In clinical settings, wIRA alone and in combination with visible light (VIS) has proven its efficacy in acute and chronic wound healing processes."( Water-filtered infrared a irradiation in combination with visible light inhibits acute chlamydial infection.
Blenn, C; Borel, N; Koschwanez, M; Marti, H; Pesch, T, 2014
)
0.4

Bioavailability

ExcerptReferenceRelevance
"The design of targeted oral liposomes is anticipated to improve the systemic delivery of poorly absorbed agents, such as proteins and peptides."( Folic acid-PEO-labeled liposomes to improve gastrointestinal absorption of encapsulated agents.
Anderson, KE; Rogers, JA; Stevenson, BR, 1999
)
0.3
" These findings suggest that L-152,804 is a selective and potent non-peptide Y5 antagonist with oral bioavailability and brain penetrability."( L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist.
Fukami, T; Fukuroda, T; Hidaka, M; Ihara, M; Ishihara, A; Ishii, Y; Ito, J; Iwaasa, H; Kanatani, A; MacNeil, DJ; Nakamura, K; Okabe, T; Okamoto, O; Van der Ploeg, LH, 2000
)
0.31
" The pharmacokinetics of DMXAA in plasma, liver and tumour tissue indicated a bioavailability of 73%."( Oral activity and pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice.
Baguley, BC; Ching, LM; Kestell, P; Zhao, L, 2002
)
0.31
" Neither LY379268 nor LY341495 influenced the central bioavailability and the local half-life of MPTP, as shown by measurements of the toxin and its active metabolite, MPP(+), in the striatum."( Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Battaglia, G; Biagioni, F; Bruno, V; Busceti, CL; Fornai, F; Nicoletti, F; Paparelli, A; Pontarelli, F; Ruggieri, S, 2003
)
0.32
" The relatively low bioavailability of catechins reported after oral exposure to green tea argues, however, against a causal role of these constituents in the reported liver disorders."( Toxicity of green tea extracts and their constituents in rat hepatocytes in primary culture.
Baumgart, A; Guédon, D; Kreuter, MH; Netsch, MI; Schmidlin, CB; Schmidt, M; Schmitz, HJ; Schrenk, D, 2005
)
0.33
"The aim of this study was to assess the efficacy of a structurally novel, potent, selective mGlu2/3 receptor agonist with improved bioavailability (LY404039) in animal models predictive of antipsychotic and anxiolytic efficacy."( In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders.
Griffey, KI; Johnson, BG; Knitowski, KM; McKinzie, DL; Monn, JA; Perry, KW; Rorick-Kehn, LM; Salhoff, CR; Schoepp, DD; Tizzano, JP; Witkin, JM, 2007
)
0.34
" The hazard to the environment represented by waste leachates depends not only on their chemical composition, but also on the mobility and bioavailability of toxic contaminants in soils."( The use of bioassays for the risk assessment of toxic leachates: an experimental study.
Blinova, I; Irha, N, 2007
)
0.34
" In continuation of the tests investigating the factors limiting bioavailability of boswellic acids, the present study examined the permeability of KBA and AKBA in human Caco-2 cell lines."( Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2.
Abdel-Tawab, M; Fricker, G; Hummel, J; Kanzer, J; Krüger, P; Schubert-Zsilavecz, M, 2009
)
0.35
" However, the poor oral bioavailability of NAAG and 2-PMPA limits their practical use in humans."( Oral administration of the NAALADase inhibitor GPI-5693 attenuates cocaine-induced reinstatement of drug-seeking behavior in rats.
Ashby, CR; Gardner, EL; Li, J; Peng, XQ; Slusher, BS; Thomas, A; Wozniak, K; Xi, ZX, 2010
)
0.36
"This study was aimed to synthesize polymeric excipients with improved mucoadhesive, cohesive and in situ-gelling properties to assure a prolonged retention time of dosage forms at a given target site, thereby achieving an increased uptake and improved oral bioavailability of certain challenging therapeutic agents such as peptides and proteins."( Preactivated thiomers as mucoadhesive polymers for drug delivery.
Bernkop-Schnürch, A; Dünnhaupt, S; Hintzen, F; Iqbal, J; Müller, C; Shahnaz, G, 2012
)
0.38
" Our efforts resulted in the identification of a potent, orally bioavailable CNS penetrant compound that exhibited in vivo efficacy."( Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease.
Chen, K; Cheng, AC; Dineen, TA; Epstein, O; Fremeau, RT; Graceffa, R; Hickman, D; Huang, H; Kiang, YH; La, DS; Louie, S; Luo, Y; Patel, VF; Wahl, RC; Wen, PH; Whittington, DA; Wood, S, 2012
)
0.63
" However, the diffusion and bioavailability of test substances in 3D matrices used in in vitro toxicological assays must be considered and adaption of the protocols is necessary for direct comparison with the traditional 2D models."( Cell viability assessment using the Alamar blue assay: a comparison of 2D and 3D cell culture models.
Baranska, M; Blanco, A; Bonnier, F; Byrne, HJ; Garcia-Munoz, A; Keating, ME; Majzner, K; Wróbel, TP, 2015
)
0.42
" Compound 4 h, which contains a substituted tricyclic 6-6-6 xanthene, demonstrated broad genotypic spectrum, compelling potency, and good oral bioavailability with dose-dependent drug exposure level in multiple animal species."( Potent bisimidazole-based HCV NS5A inhibitors bearing annulated tricyclic motifs.
Colonno, R; Huang, N; Huang, Q; Huq, A; Lau, M; Li, L; Peng, E; Zhong, M, 2014
)
0.4
"The poor bioavailability of mangiferin (MGF) is a major obstacle on its further development."( Pharmacokinetics of mangiferin and its metabolite-norathyriol, Part 2: Influence of UGT, CYP450, P-gp, and enterobacteria and the potential interaction in Rhizoma Anemarrhenae decoction with timosaponin B2 as the major contributor.
Gao, Y; Guo, X; Hu, P; Huang, C; Li, Z; Lian, S; Ma, Y; Tian, X; Xu, Z, 2016
)
0.43
" According to the results, the absorption rate constant was (0."( [Nasal resorption of prim-O-glucosylcimifugin and 5-O-methylvisammioside in rats].
Chen, XF; Jiang, ZT; Pan, JH; Wang, JC; Wang, JP; Wang, TF, 2017
)
0.46
" Results showed that norathyriol was well absorbed, as indicated by its absolute bioavailability of 30."( Absorption, Metabolism, and Pharmacokinetics Profiles of Norathyriol, an Aglycone of Mangiferin, in Rats by HPLC-MS/MS.
Chen, S; Cheng, M; Guo, X; Hu, P; Huang, C; Liu, H; Shi, H; Shi, Z; Tian, X; Xu, Z, 2018
)
0.48
" However, short biological half-life and low oral bioavailability severely limit its clinical application."( Preparation and preliminary pharmacokinetics study of GNA-loaded zein nanoparticles.
Chen, W; Cheng, W; Dong, Q; Hong, L; Qian, J; Wang, B; Zha, L; Zhang, C, 2019
)
0.51
"GNA-ZN-NPs significantly enhanced the oral bioavailability and prolonged half-life of GNA, providing a promising oral drug delivery system to improve in vivo pharmacokinetic behaviour of GNA."( Preparation and preliminary pharmacokinetics study of GNA-loaded zein nanoparticles.
Chen, W; Cheng, W; Dong, Q; Hong, L; Qian, J; Wang, B; Zha, L; Zhang, C, 2019
)
0.51
" Among the numerous methods of determining the antioxidant properties of samples of plant material, biological methods that provide information about not only the in vivo antioxidant potential of samples but also their metabolism and bioavailability are increasingly valued."( Resazurin Method for Evaluation of Bioactive Compounds from Cranberry Extracts Using the Metabolic Activity of a ΔSOD1 Mutant of Saccharomyces cerevisiae Yeast Under Severe Osmotic Stress.
Rybczyńska-Tkaczyk, K; Święciło, A, 2020
)
0.56
" Herein, we aimed to formulate BXL-loaded solid lipid nanoparticles (SLN-BXL) to improve the bioavailability and interaction with the skin, and also to investigate the protective impact against intracellular ROS generation in HFF-1 in comparison with the drug-free situation."( Benzo[k,l]xanthene Lignan-Loaded Solid Lipid Nanoparticles for Topical Application: A Preliminary Study.
Acquaviva, R; Cardullo, N; Castelli, F; La Mantia, A; Muccilli, V; Russo, S; Sarpietro, MG; Torrisi, C, 2022
)
0.72

Dosage Studied

ExcerptRelevanceReference
" For inhalation aerosol dosage forms intended for prophylactic use, the drug entity with slower systemic absorption probably would be more desirable than the drug entity with rapid absorption."( Pulmonary absorption studies utilizing in situ rat lung model: designing dosage regimen for bronchial delivery of new drug entities.
Amaro, AA; Chowhan, ZT, 1976
)
0.26
" Both RU 31156 and DSCG inhibited anaphylactic bronchoconstriction in the rat, giving bell-shaped dose-response curves."( Inhibition of experimental immediate hypersensitivity reactions by a novel xanthone, RU 31156.
James, GW; Miller, P, 1978
)
0.26
" The dosage causing a 50% inhibition culture growth (ID50) and minimum concentration, caused by the detachment of the cell from the vessel wall, were determined."( [Effects of drugs on cell culture (II)].
Kameyama, T; Mukaide, A, 1975
)
0.25
"To establish a dose-response of neurotoxic effects to daily oral doses of the mycotoxin secalonic acid D (SAD), as well as to correlate the neonatal behavioral responses to smaller doses of SAD with the attendant neurochemical effects in mice, 5 neonates of each sex were placed with each mother and 4 litters were treated orally with 0 to 5 mg/kg of SAD daily from postnatal day (PND) 3 through 35."( Neurotoxic effects of secalonic acid D in mice during subchronic postnatal exposure.
Montella, PG; Reddy, CS, 1991
)
0.28
" Increasing concentrations (10(-7)-10(-4) M) of AH6809 (which possesses negligible intrinsic agonist activity) produced parallel shifts to the right of dose-response curves to PGD2 and ZK110841."( Evaluation of ZK110841 and AH6809, an agonist and an antagonist of prostaglandin DP-receptors on human platelets, with a PGD2-responsive cell line from bovine embryonic trachea.
Hayaishi, O; Ito, S; Negishi, M; Okuda, E; Sugama, K, 1990
)
0.28
"01) elevations in plasma corticosterone concentrations were seen 24 and 48 hr following dosing of SAD in NaHCO3 with concentrations reaching a peak just prior to the onset of shelf elevation and fusion."( Role of maternal plasma corticosterone elevation in the teratogenicity of secalonic acid D in mice.
Eldeib, MM; Reddy, CS, 1990
)
0.28
"Significant destruction of the Pollard III rat prostate adenocarcinoma was achieved by treatment with rhodamine 123 at a dosage of 15 mg/kg every other day for 33 to 38 days."( Use of rhodamine 123 in the treatment of the Pollard III rat prostate adenocarcinoma.
Arcadi, JA, 1990
)
0.28
" A significant dose-response effect in olfactory discrimination existed between the groups exposed to postnatal SAD."( Behavioral and developmental effects in suckling mice following maternal exposure to the mycotoxin secalonic acid D.
Bolon, B; St Omer, VE, 1989
)
0.28
" The resulting dose-survival curve was identical to the dose-response curve of RS cells treated with R123 alone."( Relationship between cellular accumulation of rhodamine 123 (R123) and cytotoxicity in B16 melanoma cells.
Gan, L; Krag, DN; Tao, SZ; Theon, AP; Wardell, J, 1989
)
0.28
"00004 microgram/ml dosage (IC50)."( Actinoplanones C, D, E, F and G, new cytotoxic polycyclic xanthones from Actinoplanes sp.
Kobayashi, K; Kodama, M; Mikawa, T; Nishino, C; Ohya, J; Sato, S; Shiobara, Y, 1988
)
0.27
" Peritonitis was observed in chicks given the high dosage STG."( Effects of repeated intra-abdominal injections of sterigmatocystin on relative organ weights, concentration of serum and liver constituents, and histopathology of certain organs of the chick.
Frohlich, AA; Marquardt, RR; Sreemannarayana, O, 1988
)
0.27
" Dose-response relationships were established for R6G and 3-mercaptopicolinic acid, and a nontoxic dose of the compounds was selected for subsequent experiments."( Reduction of the growth rate of the Walker 256 tumor in rats by rhodamine 6G together with hypoglycemia.
Burns, HJ; Calman, KC; Fearon, KC; Plumb, JA, 1987
)
0.27
" Rhodamine was administered subcutaneously every other day at a dosage of 15 mg/Kg body weight for fifty-two days."( Rhodamine-123 as effective agent in rat prostate tumor R3327-H. Preliminary report.
Arcadi, JA, 1986
)
0.27
" Loss of these adducts from liver DNA was observed to exhibit a triphasic profile: rapid loss during the first 24 h (t 1/2 = 12 h) followed by a slower decline from 1 to 14 days post dosing (t 1/2 = 7 days) and an extremely slow decline from days 14 to 105 post treatment (t 1/2 = 109 days)."( Formation and persistence of sterigmatocystin--DNA adducts in rat liver determined via 32P-postlabeling analysis.
Irvin, TR; Randerath, K; Reddy, MV, 1985
)
0.27
" A dose-response relationship was observed between the dose of 10(-6) and 1 mM."( Acute cytogenetic effect of sterigmatocystin on rat bone-marrow cells in vivo.
Chattopadhyay, SC; Fujie, K; Gotoh-Mimura, K; Sugiyama, T; Ueda, N, 1984
)
0.27
"Rhodamine 6G inhibited ATP hydrolysis by oligomycin-sensitive ATPase, purified from rat liver mitochondria, in good accord with the dose-response curve for its inhibition of energy transduction of ATP synthesis in mitochondria, but it did not inhibit ATP hydrolysis by purified F1."( Rhodamine 6G, inhibitor of both H+-ejections from mitochondria energized with ATP and with respiratory substrates.
Higuti, T; Nakasima, S; Niimi, S; Ohe, T; Saito, R; Tani, I; Yoshimura, T, 1980
)
0.26
" Increasing doses (5 pg kg(-1)-500 ng kg-1) of ONO-NT-012 produced parallel shifts to the right of the dose-response curves to PGE2."( Blockade by ONO-NT-012, a unique prostanoid analogue, of prostaglandin E2-induced allodynia in conscious mice.
Hayaishi, O; Hyodo, M; Ito, S; Minami, T; Nishihara, I; Sakamoto, K, 1995
)
0.29
" The therapy lasted for 4 weeks; the dosage was 300 mg three times daily."( Hypericum treatment of mild depressions with somatic symptoms.
Hübner, WD; Lande, S; Podzuweit, H, 1994
)
0.29
" The dosage was 3 x 300 mg hypericum extract LI 160 or 3 x 25 mg imipramine daily."( Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: randomized double-blind study with 135 outpatients.
Arnoldt, KH; Hübner, WD; Vorbach, EU, 1994
)
0.29
" During long-term dosing (3 x 300 mg/day), a steady-state was reached after 4 days."( Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers.
Brockmöller, J; Kerb, R; Ploch, M; Roots, I; Staffeldt, B, 1994
)
0.29
" The dosage was typically 300 to 900 mg total extract daily; the therapy duration was 2 to 6 weeks."( Clinical investigation of the antidepressant effectiveness of hypericum.
Harrer, G; Schulz, V, 1994
)
0.29
" The preferential repression of EPX on the cell proliferation of 212 and T24 cells was further demonstrated by decreasing Ha-ras oncogene expression levels while EPX dosage increased."( Antitumor effect of 2,6-di(2,3-epoxypropoxy)xanthone on tumor cell lines.
Lin, CN; Liu, HS; Won, SJ,
)
0.13
" Many supplements are potent drugs that lack sufficient data on safety, dose-response relationships, drug interactions, and purity."( Over-the-counter psychotropics: a review of melatonin, St John's wort, valerian, and kava-kava.
Guenther, G; Heiligenstein, E, 1998
)
0.3
" The dosage schedule was elaborated for the application of identical amounts of hyperforin in both extracts in each dosing group."( Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
Dimpfel, W; Mannel, M; Schober, F, 1998
)
0.3
" After 3 weeks of treatment, dosage in 128 patients (21."( St. John's Wort for depressive disorders: results of an outpatient study with the Hypericum preparation HYP 811.
Mueller, BM,
)
0.13
" After 3 weeks of treatment, the dosage could be reduced to one capsule per day in 35."( Effects of hypericum extract HYP 811 in patients with psychovegetative disorders.
Mueller, BM,
)
0.13
" In dose-response studies, SLIGRL-NH(2) induced concentration-dependent increases in PGE(2) release (EC(50)=20."( Role of PGE(2) in protease-activated receptor-1, -2 and -4 mediated relaxation in the mouse isolated trachea.
Henry, PJ; Knight, DA; Lan, RS; Stewart, GA, 2001
)
0.31
"1 monotherapies are complicated by a narrow range of effective doses, combined therapy was less dosage dependent."( Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
Ching, LM; Kanwar, JR; Kanwar, RK; Krissansen, GW; Pandey, S, 2001
)
0.31
" However, LY487379 markedly potentiated glutamate-stimulated [35S]GTPgammaS binding in a concentration-dependent manner at hmGluR2, shifting the glutamate dose-response curve leftward by 3-fold and increasing the maximum levels of [35S]GTPgammaS stimulation."( Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2.
Bain, G; Bristow, LJ; Chavez-Noriega, LE; Daggett, LP; Jachec, C; Morales, S; Pinkerton, AB; Rao, SP; Rowe, BA; Schaffhauser, H; Varney, MA; Vernier, JM; Yin, R, 2003
)
0.32
" Careful consideration of all steps, starting from caged InsP(3) loading into the cells by electroporation, up to photoliberation upon UV exposure, allowed to derive a dose-response relation that revealed a first part with a flattening ATP release response in the below 10microM InsP(3) concentration range and a second phase of steeply increasing ATP release in response to above 10microM InsP(3) stimulation."( Electroporation loading and photoactivation of caged InsP3: tools to investigate the relation between cellular ATP release in response to intracellular InsP3 elevation.
Braet, K; Cabooter, L; Leybaert, L; Mabilde, C; Rapp, G, 2004
)
0.32
" Throughout the dosing range, ATI22-107 induced much smaller, if any, increases in diastolic [Ca(2+)](i), T(25), and T(75)."( Pharmacological effects of ATI22-107 [2-(2-{2-[2-chloro-4-(6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl)-phenoxy]-acetylamino}-ethoxymethyl)-4-(2-chloro-phenyl)-6-methyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid dimethyl ester)], a novel dual pharmacophore, o
Bednarik, DP; Houser, SR; Jung, AS; Margulies, KB; Mills, GD; Quaile, MP, 2005
)
0.33
" Results were measured with a fluorescent multiwell plate reader and dose-response curves were obtained successfully with both procedures."( Comparing a ciliate and a fish cell line for their sensitivity to several classes of toxicants by the novel application of multiwell filter plates to Tetrahymena.
Bols, NC; Dayeh, VR; DeWitte-Orr, SJ; Grominsky, S; Lee, LE; Lynn, DH; Sotornik, D; Yeung, CR,
)
0.13
" We investigated the effect of inhibition of osteoclastic acidification in vivo by using the rat ovariectomy model with twice daily oral dosing of NS3696 at 50 mg/kg for 6 weeks."( Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption.
Bollerslev, J; Christiansen, C; Christophersen, P; Dziegiel, MH; Gram, J; Heegaard, AM; Henriksen, K; Karsdal, MA; Martin, TJ; Schaller, S; Sørensen, MG, 2005
)
0.33
" The mitogenic response of leukocytes of chinook salmon exposed to p,p'-DDE in vivo exhibited a biphasic dose-response relationship."( p,p'-DDE depresses the immune competence of chinook salmon (Oncorhynchus tshawytscha) leukocytes.
Leong, JA; Misumi, I; Nakanishi, T; Schreck, CB; Vella, AT, 2005
)
0.33
" In the operant procedure, L-152,804 (10 and 20 mg/kg, ip) significantly reduced both the dosage of self-administered ethanol (g/kg/1-h) and the total number of ethanol-reinforced responses."( The neuropeptide-Y Y5 receptor antagonist L-152,804 decreases alcohol self-administration in inbred alcohol-preferring (iP) rats.
Hodge, CW; Overstreet, DH; Schroeder, JP, 2005
)
0.33
" TC50 values were calculated from fitted dose-response curves."( Cytotoxicity of resin monomers on human gingival fibroblasts and HaCaT keratinocytes.
Brook, IM; Moharamzadeh, K; Scutt, AM; Van Noort, R, 2007
)
0.34
" We also noted differences in the dose-response relationships for NF-kappaB activation between lymphoid and endothelial lines that were species independent."( A comparison of the ability of DMXAA and xanthenone analogues to activate NF-kappaB in murine and human cell lines.
Baguley, BC; Ching, LM; Drummond, CJ; Kieda, C; Reddy, CB; Schooltink, MA; Woon, ST, 2005
)
0.33
" A micellar formulation of paclitaxel prodrug (PAX7'C(6)) was dosed intravenously to rats (10 mg/kg) and compared to Taxol (paclitaxel in CrEL:EtOH) and PAX7'C(6) in CrEL:EtOH as controls at the same dose."( Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity.
Davies, NM; Forrest, ML; Kwon, GS; Ohgami, Y; Remsberg, CM; Yáñez, JA, 2008
)
0.35
" From dose-response curve, half maximal inhibitory concentration (IC50) was determined for each strain."( Assessment of Mycosphaerella graminicola resistance to azoxystrobin.
Deweer, C; Halama, P; Morand, E; Reignault, P; Siah, A, 2008
)
0.35
" The effects of parameters including reactant dosing sequence, Fe(II)/Oxone molar ratio and concentration, solution pH, and inorganic salts on the process performance have been investigated."( Degradation of a xanthene dye by Fe(II)-mediated activation of Oxone process.
Chu, W; Wang, YR, 2011
)
0.37
" Hits were confirmed for activity against biofilms with dose-response measurements."( Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms.
Diamond, SL; LaFleur, MD; Lewis, K; Lucumi, E; Napper, AD, 2011
)
0.37
"This study was aimed to synthesize polymeric excipients with improved mucoadhesive, cohesive and in situ-gelling properties to assure a prolonged retention time of dosage forms at a given target site, thereby achieving an increased uptake and improved oral bioavailability of certain challenging therapeutic agents such as peptides and proteins."( Preactivated thiomers as mucoadhesive polymers for drug delivery.
Bernkop-Schnürch, A; Dünnhaupt, S; Hintzen, F; Iqbal, J; Müller, C; Shahnaz, G, 2012
)
0.38
"In self-administration, L-152,804 prominently decreased nose-poking for the peak dose of cocaine and shifted the dose-response curve for cocaine downward."( Neuropeptide Y Y5 receptor antagonism attenuates cocaine-induced effects in mice.
Bengtsen, CH; Christiansen, SH; Dencker, D; Fink-Jensen, A; Jensen, M; Loland, CJ; Petersen, JH; Sørensen, G; Weikop, P; Woldbye, DP; Wörtwein, G, 2012
)
0.38
" Different groups of rats received bilateral microinjections of LY37 into BA at two dosage ranges (3."( Effects of microinjections of Group II metabotropic glutamate agents into the amygdala on sleep.
Dong, E; Sanford, LD; Wellman, LL; Yang, L, 2012
)
0.38
" Dose-response curves for fluorescein and Texas Red based on USL concentration gradients near the surface of the Malpighian tubule were comparable to those based on collection and analysis of secreted fluid droplets."( Determining rates of epithelial solute transport by optical measurement of fluorochrome concentration gradients in the unstirred layer.
O'Donnell, MJ; Seabrooke, S, 2012
)
0.38
" We developed a cisplatin dose-response curve using a transgenic line of zebrafish that expresses membrane-targeted green fluorescent protein under the control of the Brn3c promoter/enhancer."( Dimethyl sulfoxide (DMSO) exacerbates cisplatin-induced sensory hair cell death in zebrafish (Danio rerio).
Cotanche, DA; Gleichman, JS; Kramer, MD; Matsui, JI; Mueller, MA; Sibrian-Vazquez, M; Steyger, PS; Strongin, RM; Uribe, PM; Wang, Q, 2013
)
0.39
" Pretreatment with gallein produced a dose-dependent potentiation of morphine-mediated antinociception, producing up to a 10-fold leftward shift in the morphine dose-response curve and extending the duration of antinociception induced by a single dose of morphine."( Inhibition of Gβγ-subunit signaling potentiates morphine-induced antinociception but not respiratory depression, constipation, locomotion, and reward.
Bidlack, JM; Carey, AN; Hoot, MR; McLaughlin, JP; Reilley, KJ; Sypek, EI, 2013
)
0.39
" pylori infection, reducing colony counts to below the limit of detection after oral dosing of 25 mg/kg/day for 3 days."( In vitro and in vivo activities of HPi1, a selective antimicrobial against Helicobacter pylori.
Charnuska, D; Chen, C; Coleman, K; Gavrish, E; Han, A; LaFleur, MD; Lee, RE; Lewis, K; Lister, I; North, EJ; Shrestha, B; Williams, B; Yang, L, 2014
)
0.4
" The new more rapid and resource efficient approach has clear advantages: Dose-response curves show lower variability and the two endpoints are measured on the same cells."( A fast Resazurin-based live viability assay is equivalent to the MTT-test in the KeratinoSens assay.
Emter, R; Natsch, A, 2015
)
0.42
"The EC 50 of the dose-response curves correlated well with Etest MIC values (Pearson's r  = 0."( A new rapid resazurin-based microdilution assay for antimicrobial susceptibility testing of Neisseria gonorrhoeae.
Althaus, CL; Desilvestro, V; Foerster, S; Hathaway, LJ; Unemo, M, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
xanthene
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency6.30960.044717.8581100.0000AID485294
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency11.22020.707936.904389.1251AID504333
chromobox protein homolog 1Homo sapiens (human)Potency89.12510.006026.168889.1251AID540317
gemininHomo sapiens (human)Potency0.06020.004611.374133.4983AID624296; AID624297
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency39.81070.251215.843239.8107AID504327
Rap guanine nucleotide exchange factor 3Homo sapiens (human)Potency125.89206.309660.2008112.2020AID720707
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Amine oxidase [flavin-containing] AHomo sapiens (human)IC50 (µMol)24.80000.00002.37899.7700AID1888748
Amine oxidase [flavin-containing] BHomo sapiens (human)IC50 (µMol)7.42000.00001.89149.5700AID1888749
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (35)

Processvia Protein(s)Taxonomy
angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 3Homo sapiens (human)
signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 3Homo sapiens (human)
associative learningRap guanine nucleotide exchange factor 3Homo sapiens (human)
Rap protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of actin cytoskeleton organizationRap guanine nucleotide exchange factor 3Homo sapiens (human)
negative regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
intracellular signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of GTPase activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of protein export from nucleusRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of stress fiber assemblyRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
establishment of endothelial barrierRap guanine nucleotide exchange factor 3Homo sapiens (human)
cellular response to cAMPRap guanine nucleotide exchange factor 3Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 3Homo sapiens (human)
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
response to xenobiotic stimulusAmine oxidase [flavin-containing] BHomo sapiens (human)
response to toxic substanceAmine oxidase [flavin-containing] BHomo sapiens (human)
response to aluminum ionAmine oxidase [flavin-containing] BHomo sapiens (human)
response to selenium ionAmine oxidase [flavin-containing] BHomo sapiens (human)
negative regulation of serotonin secretionAmine oxidase [flavin-containing] BHomo sapiens (human)
phenylethylamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
substantia nigra developmentAmine oxidase [flavin-containing] BHomo sapiens (human)
response to lipopolysaccharideAmine oxidase [flavin-containing] BHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to ethanolAmine oxidase [flavin-containing] BHomo sapiens (human)
positive regulation of dopamine metabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
hydrogen peroxide biosynthetic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to corticosteroneAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein domain specific bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
electron transfer activityAmine oxidase [flavin-containing] BHomo sapiens (human)
identical protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (14)

Processvia Protein(s)Taxonomy
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
cortical actin cytoskeletonRap guanine nucleotide exchange factor 3Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
microvillusRap guanine nucleotide exchange factor 3Homo sapiens (human)
endomembrane systemRap guanine nucleotide exchange factor 3Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
lamellipodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
filopodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
extracellular exosomeRap guanine nucleotide exchange factor 3Homo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial envelopeAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] BHomo sapiens (human)
dendriteAmine oxidase [flavin-containing] BHomo sapiens (human)
neuronal cell bodyAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (17)

Assay IDTitleYearJournalArticle
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1888748Inhibition of recombinant human MAO-A expressed in baculovirus infected BTI insect cells using kynuramine as substrate after 20 mins by fluorescence spectrophotometric assay2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
AID1888749Inhibition of recombinant human MAO-B expressed in baculovirus infected BTI insect cells using kynuramine as substrate after 20 mins by fluorescence spectrophotometric assay2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
AID1888750Selectivity index, ratio IC50 for recombinant human MAO-B to IC50 for recombinant human MAO-A2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4,770)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901041 (21.82)18.7374
1990's912 (19.12)18.2507
2000's1362 (28.55)29.6817
2010's1260 (26.42)24.3611
2020's195 (4.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.35 (24.57)
Research Supply Index8.54 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index72.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials92 (1.83%)5.53%
Reviews96 (1.91%)6.00%
Case Studies22 (0.44%)4.05%
Observational0 (0.00%)0.25%
Other4,810 (95.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]